Pulmonx Price to Book Ratio 2019-2024 | LUNG
Historical price to book ratio values for Pulmonx (LUNG) over the last 10 years. The current price to book ratio for Pulmonx as of May 15, 2025 is 1.69.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Pulmonx Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-15 | 3.42 | 1.59 | |
| 2024-12-31 | 6.79 | $2.16 | 3.15 |
| 2024-09-30 | 8.29 | $2.38 | 3.49 |
| 2024-06-30 | 6.34 | $2.58 | 2.45 |
| 2024-03-31 | 9.27 | $2.85 | 3.26 |
| 2023-12-31 | 12.75 | $3.07 | 4.15 |
| 2023-09-30 | 10.33 | $3.28 | 3.15 |
| 2023-06-30 | 13.11 | $3.52 | 3.72 |
| 2023-03-31 | 11.18 | $3.81 | 2.93 |
| 2022-12-31 | 8.43 | $4.10 | 2.06 |
| 2022-09-30 | 16.66 | $4.37 | 3.81 |
| 2022-06-30 | 14.72 | $4.62 | 3.19 |
| 2022-03-31 | 24.81 | $4.91 | 5.05 |
| 2021-12-31 | 32.07 | $5.23 | 6.13 |
| 2021-09-30 | 35.98 | $5.51 | 6.53 |
| 2021-06-30 | 44.12 | $5.74 | 7.69 |
| 2021-03-31 | 45.74 | $6.05 | 7.56 |
| 2020-12-31 | 69.02 | $6.34 | 10.89 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.131B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.096B | 54.00 |
| Hims & Hers Health (HIMS) | United States | $13.681B | 142.14 |
| Tempus AI (TEM) | United States | $11.156B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.596B | 71.81 |
| IRhythm Technologies (IRTC) | United States | $4.484B | 0.00 |
| Privia Health (PRVA) | United States | $2.963B | 202.50 |
| Enovis (ENOV) | United States | $2.069B | 11.53 |
| Schrodinger (SDGR) | United States | $1.747B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.691B | 0.00 |
| Phreesia (PHR) | United States | $1.537B | 0.00 |
| Omnicell (OMCL) | United States | $1.346B | 23.74 |
| Azenta (AZTA) | United States | $1.233B | 57.32 |
| 10x Genomics (TXG) | United States | $1.115B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.517B | 154.50 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Claritev (CTEV) | United States | $0.435B | 0.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 825.00 |
| Health Catalyst (HCAT) | United States | $0.291B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.146B | 0.00 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| MDxHealth SA (MDXH) | Belgium | $0.084B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| Outset Medical (OM) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |